TruAlt Bioenergy LtdQ1 FY26
TruAlt Bioenergy Ltd Q1 FY26 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹468P/E: 28.6Market Cap: ₹4.2K CrSector: Agricultural Food & other Products
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
Yes
Order
No
Capex
Yes
2 of 5 growth signals are positive.
Full analysisRevenue guidance
Category 2- →TruAlt Bioenergy aims to achieve a minimum of 40 crore litres ethanol sales volume, with a bonus target of 55 crore litres (Page 23).
- →Current ethanol sales run rate is 2.2 crore litres/month; expected increase to about 5 crore litres/month once additional 15 crore litres supply from OMCs is implemented (Page 5).
- →Revenue run rate target from ethanol is around INR 350-400 crores per month if 6 crore litres capacity is utilized (Page 27).
- →Execution of 15 crore litres additional ethanol order is pending government/OMC approval, expected after 24-30 months (FY29) (Page 29).
- →Exploration of export opportunities and sustainable aviation fuel plans to diversify revenue streams and improve capacity utilization (Pages 5, 23, 29).
- →Compressed Biogas (CBG) business shows strong growth potential with steady 85%+ capacity utilization and EBITDA more than 45%, aiming for phased scaling beyond current 10+4 planned plants (Pages 17, 21).
- →Fuel retail vertical expected to drive additional revenue growth with 75 planned outlets, seven currently operational showing INR 105 crores revenue from them (Page 18).
Margin guidance
Category 3- →TruAlt Bioenergy aims to achieve at least 40 crore litres ethanol sales volume by FY27, with a bonus target of 55 crore litres, reflecting strong volume growth potential.
- →Additional revenue streams planned from sustainable aviation fuel and ethanol exports to fully utilize ethanol capacity.
- →CBG business shows high margin potential with expected EBITDA margins around 50-60%; scalability planned through phased capex after current plants stabilize.
- →Fuel retail vertical expected to expand significantly with plans for about 75 retail outlets, potentially generating substantial incremental revenue.
- →Management cautious on timelines; new plant commissioning slated for FY29 (24-30 months out), which will bring one-time income after commissioning.
- →Despite recent challenges and lower EBITDA growth impacting profits, long-term outlook includes diversified revenue streams and increasing blending mandates driving demand.
- →Marketing and advertisement spend to increase to support fuel retail business expansion, aiding growth.
- →Overall, earnings expected to grow with volume ramp-up, policy tailwinds, and diversification beyond government subsidies.
3 more insights locked — sign up free to unlock
Fundraise plans
Yes- →TruAlt Bioenergy plans to fund the expansion of their CBG plants through a mix of debt and equity.
- →The company will invest 51% equity, while JV partners Sumitomo and GAIL will contribute 49%.
- →Capital has already been provisioned and infused into subsidiaries for this purpose.
- →Debt financing has been tied up, notably with NABARD at an interest rate of 8.65% for Sumitomo plans.
- →The debt-to-equity mix targeted for funding is approximately 70% debt and 30% equity.
- →Management acknowledged the need for more investor engagement on fundraising updates going forward.
Order book
No- →TruAlt Bioenergy has existing purchase orders (POs) from private OMCs for about 8 crore litres of ethanol, with only 1.6 crore litres supplied so far; balance 6+ crore litres pending lifting due to delay in indent issuance.
- →A court order dated February 4, 2026, mandates OMCs to lift an additional 15 crore litres within three months; this has not been implemented yet due to ongoing litigation involving LTOA holders and OMCs.
- →Total expected orderbook for FY 2027 including OMC allocations is approximately 40 crore litres (public + private OMCs) plus pending 15 crore litres from the court order, targeting a peak capacity of around 55 crore litres.
- →Inventory of nearly INR500 crores is built awaiting order execution.
- →Implementation of pending orders expected to resume post resolution of related court cases around June to September 2026.
Capex plans
Yes- →TruAlt Bioenergy plans to commission a new plant expected within 24 to 30 months (FY29) for which they will receive a one-shot payment once operational.
- →They are investing in multiple CBG (Compressed Bio-Gas) plants: 9-10 to be live by current year and 10-15 more planned, funded via a 70:30 debt-to-equity mix.
- →Funding includes 51% investment from TruAlt and 49% from JV partners Sumitomo and GAIL, with NABARD loans at favorable interest rates (around 8.65%).
- →A fourth CBG plant is planned pending land clearance, aiming for a total of 11 units.
- →Expansion into fuel retail vertical with plans for up to 75 outlets to drive future revenue growth.
- →Investments also target diversification into sustainable aviation fuel and export of ethanol to reduce dependence on government policy.
How does TruAlt Bioenergy Ltd rank vs peers in Agricultural Food & other Products?
Pro feature1TruAlt Bioenergy Ltd
Rev 2Mar 3
See full Agricultural Food & other Products sector rankings
Want more stocks like TruAlt Bioenergy Ltd?
Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.
Build my portfolio